Zephyrnet Logo

Tag: ANVISA

Therma Bright Reports Performance of Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study

Toronto, Ontario--(Newsfile Corp. - June 17, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid...

Design Transfer: A practical Approach

In the framework of the process of Design and Development, the design transfer (DT) corresponds to the last phase, where the specifications are...

Therma Bright Enters into Agreement to Distribute a 15 Minute Rapid COVID-19 Antibody Test

Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid...

ISO 2859 and AQL Sampling Methodology

The ISO 2859 has become with the time an essential tool not only for medical device manufactures but also for all the manufacturing...

Hydroxychloroquine is not effective when given late in mild-to-moderate COVID-19 patients, a new Brazilian study published in New England Journal of Medicine shows

Everyone wants to “follow the science.” However, with coronavirus claiming over half a million lives around the world, doctors and scientists are experimenting...

Guest Post: The legal status of CBD oil in Brazil

Brian Cusack writes…The 19th century. This is when cannabis landed in Brazil, introduced by the Portuguese colonizers. Fast forward, the booming cannabis industry...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?